US to announce list of drugs for pricing negotiations 1st September
President Joe Biden in August signed into law the Inflation Reduction Act, which, among its provisions for the first time, allows the federal Medicare health plan for people aged 65 years and older, and the disabled, to negotiate prices on some of the most expensive drugs
The United States (US) government will announce a list of 10 prescription drugs for which it plans to negotiate the prices for Medicare recipients on 1st September, and the prices a year later, a top Biden administration official said yesterday.
President Joe Biden in August signed into law the Inflation Reduction Act, which, among its provisions for the first time, allows the federal Medicare health plan for people aged 65 years and older, and the disabled, to negotiate prices on some of the most expensive drugs.
The US Department of Health and Human Services (HHS) and the Centers of Medicare and Medicaid Services (CMS) – which oversees Medicare and the negotiation process – announced the specific timeline for the first year of negotiations yesterday.
It had previously said it would release the names of the 10 Part D high-spend brand name medicines that would be included in pricing negotiations in the fall of 2023.
Edits by EP News Bureau
- Advertisement -
Your blog is very informative. thanks for Sharing this blog.